Equillium (EQ) Change in Account Payables (2018 - 2026)
Equillium (EQ) reported Change in Account Payables of $434000.0 for Q1 2026, up 13.91% year-over-year from $381000.0 in Q1 2025, and up 1415.15% quarter-over-quarter from -$33000.0 in Q4 2025.
Equillium (EQ) Change in Account Payables (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Change in Account Payables data on file, last reported at $434000.0 in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $434000.0, up 13.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 646.09% YoY), and the FY2025 annual result was -$1.9 million, up 2.91% from the prior year.
- Change in Account Payables grew to $434000.0 in Q1 2026 per EQ's latest filing, from -$33000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.7 million in Q1 2022 and troughed at -$4.0 million in Q3 2025.
- A 5-year average of -$15705.9 and a median of $434000.0 in 2026 frame the typical range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 650.51% in 2022 and fell as far as 401.38% in 2022.
- A 5-year view of Change in Account Payables shows it stood at $1.5 million in 2022, then sank by 30.17% to $1.0 million in 2023, then sank by 190.73% to -$949000.0 in 2024, then surged by 96.52% to -$33000.0 in 2025, then soared by 1415.15% to $434000.0 in 2026.
- Business Quant data shows EQ's Change in Account Payables at $434000.0 in Q1 2026, -$33000.0 in Q4 2025, and -$4.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 434,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 434,000.00 |
| Mar 31, 2026 | 434,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Sep 30, 2025 | -4.03 Mn |
| Sep 30, 2025 | -4.03 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 381,000.00 |
| Mar 31, 2025 | 381,000.00 |
| Dec 31, 2024 | -949,000.00 |
| Dec 31, 2024 | -949,000.00 |
| Sep 30, 2024 | -843,000.00 |
| Sep 30, 2024 | -843,000.00 |
| Jun 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Mar 31, 2024 | -1.96 Mn |
| Mar 31, 2024 | -1.96 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Dec 31, 2023 | 1.05 Mn |